The development of highly effective biologics was preceded by research efforts over several decades. Advances in immunopathogenetic and molecular genetic analyses contributed significantly to the generation of these innovative system therapeutics. The Guenter Goerz Memorial Lecture of this year’s annual meeting of the Working Group for Dermatological Research was dedicated to this topic and spanned from milestones of psoriasis research to the biologics available today.
This content is machine-translated. Please contact us if you need professional translation services.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Cardiovascular risk in IBD
Cause for concern?
- Microplastics in kidneys and urine
Life in plastic … is not fantastic
- Asthma and psyche
When fear makes you lose your breath
- COPD: Update for the primary care physician
Counteract exacerbations and improve quality of life
- Stroke
Not on the brain – the latest findings on strokes
- Atopic dermatitis: choice of systemic therapy option
“It’s always an individual weighing”.
- Do low carb diets harm the heart?
Keto diet associated with hypercholesterolemia and increased risk of ASCVD
- Cardiovascular events in CKD